EU pharma legislation is going to change your business. What you make, where and how you sell it, and whether your business model is even viable.
Spain will hold the Presidency of the Council of the European Union for the fifth time in the second half of 2023, between July 1 and […]
On June 26-27, a Life Science conference is arranged for EU parliamentarians during Sweden's EU presidency.
EuropaBio, and AseBio, the Spanish Association of Biotechnology Companies, with the support of Merck, will host a summer reception to mark the beginning of the Spanish Council […]
Join us to celebrate the power of biotech at the Dutch Biotech Event 2023! About HollandBIO’s Dutch Biotech Event The program features inspiring talks by keynote […]
CEFIC Specialty Chemicals sector groups EFCG, Biochem Europe and EFG, together with SICOS, the French industry association for Fine Chemicals and Biotech, will jointly hold their first in-person Industrial Biotechnologies Day on July 4th, 2023 in Brussels.
Life sciences in Lithuania have been a priority for the government for over a decade. Accelerating faster than almost anywhere else in Europe, the sector aims to contribute 5% to Lithuania’s GDP by 2030. The close cooperation between actors of the ecosystem is one of the reason for success.
The world is at a key point of industrial and societal transition, driven by advancing technology and the need for competitive, resilient and sustainable economies.
Biotechnology is at the heart of this transition across all sectors and it is playing a significant role in shaping Europe’s future.
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of […]
NETWORKING AND PARTNERSHIPS IN BIOECONOMY AREA IFIB - International Forum on Industrial Biotechnology and Bioeconomy aims at strengthening the bioeconomy network in the Euro-Mediterranean area and to promote […]
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem.
Held annually since 2004, the TOPRA Symposium is Europe’s premier conference for healthcare regulatory affairs. With dedicated programme streams for human medicines, medical devices and IVDs, and veterinary medicines, the Symposium is the must-attend event in the regulatory affairs calendar.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
